Discontinuation report TEVA-NAPROXEN SODIUM DS

Last updated on 2019-04-11 History
Report ID 81350
Drug Identification Number 02026600
Brand name TEVA-NAPROXEN SODIUM DS
Common or Proper name NAPROXEN SODIUM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NAPROXEN SODIUM
Strength(s) 550MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-01-09
Remaining supply date 2019-02-28
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-04-11 English Compare
v2 2019-04-11 French Compare

Showing 1 to 2 of 2